-
1861
-
1862
-
1863
USER-GENERATED REVIEWS AND OFFICIAL STAR RATINGS: CAN THE TWO WORK TOGETHER IN HOTEL EVALUATION SYSTEMS?
Published 2020-05-01Get full text
Article -
1864
-
1865
-
1866
E3 ubiquitin ligase SYVN1 as a promising therapeutic target for diverse human diseases
Published 2025-02-01Get full text
Article -
1867
-
1868
-
1869
-
1870
-
1871
-
1872
-
1873
Questionnaire to Survey Cosmetic Outcomes in Laparoscopic Surgery for Colorectal Cancer
Published 2024-09-01Get full text
Article -
1874
-
1875
ArfGAP with the SH3 Domain, Ankyrin Repeat and PH Domain 1 Inversely Regulates Programmed Death-Ligand 1 Through Negative Feedback of Phosphorylated Epithelial Growth Factor Recept...
Published 2025-01-01“…Naohisa Chiba,1 Toshi Menju,1 Yumeta Shimazu,1 Toshiya Toyazaki,1 Ryota Sumitomo,1 Hideaki Miyamoto,1 Shigeyuki Tamari,1,2 Shigeto Nishikawa,1 Hiroshi Date1 1Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 2Department of Thoracic Surgery, Shizuoka City Shizuoka Hospital, Shizuoka, JapanCorrespondence: Toshi Menju, Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shigoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan, Tel +81-757514975, Email toshimnj@kuhp.kyoto-u.ac.jpBackground: Signaling pathways centered on the G-protein ADP-ribosylation factor 6 (Arf6) and its downstream effector ArfGAP with the SH3 Domain, Ankyrin Repeat and PH Domain 1 (AMAP1) drive cancer invasion, metastasis, and therapy resistance. …”
Get full text
Article -
1876
-
1877
-
1878
-
1879
-
1880
Determinants maintaining healthcare personnel’s motivation during COVID-19 pandemic in Uganda
Published 2025-01-01Get full text
Article